Amdocs Limited $DOX Stock Holdings Decreased by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. lessened its stake in Amdocs Limited (NASDAQ:DOX) by 45.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 294,274 shares of the technology company’s stock after selling 247,374 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.26% of Amdocs worth $24,145,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Ashton Thomas Private Wealth LLC increased its holdings in Amdocs by 226.9% in the third quarter. Ashton Thomas Private Wealth LLC now owns 76,084 shares of the technology company’s stock valued at $6,283,000 after buying an additional 52,810 shares during the last quarter. Penserra Capital Management LLC raised its position in shares of Amdocs by 23.6% during the 3rd quarter. Penserra Capital Management LLC now owns 123,431 shares of the technology company’s stock valued at $10,127,000 after acquiring an additional 23,550 shares in the last quarter. Running Oak Capital LLC lifted its stake in Amdocs by 4.6% during the third quarter. Running Oak Capital LLC now owns 183,194 shares of the technology company’s stock worth $15,084,000 after purchasing an additional 8,071 shares during the last quarter. Jackson Creek Investment Advisors LLC acquired a new position in Amdocs in the third quarter worth $454,000. Finally, Atlantic Union Bankshares Corp acquired a new position in Amdocs in the third quarter worth $37,000. Institutional investors own 92.02% of the company’s stock.

Amdocs Stock Up 1.3%

Amdocs stock opened at $69.23 on Friday. Amdocs Limited has a 52 week low of $66.67 and a 52 week high of $95.41. The stock has a market cap of $7.47 billion, a price-to-earnings ratio of 13.39, a PEG ratio of 1.21 and a beta of 0.40. The company’s 50-day moving average price is $79.63 and its two-hundred day moving average price is $81.77. The company has a current ratio of 1.06, a quick ratio of 1.17 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX) last posted its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 EPS for the quarter, beating analysts’ consensus estimates of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The business had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.15 billion. During the same quarter last year, the business earned $1.66 earnings per share. The business’s revenue for the quarter was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. On average, analysts expect that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be paid a dividend of $0.569 per share. This is an increase from Amdocs’s previous quarterly dividend of $0.53. This represents a $2.28 annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend is Tuesday, March 31st. Amdocs’s dividend payout ratio (DPR) is 43.91%.

Analysts Set New Price Targets

A number of brokerages have weighed in on DOX. Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a report on Tuesday, January 27th. Wall Street Zen upgraded shares of Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Stifel Nicolaus decreased their target price on Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, February 4th. Bank of America lowered their target price on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a report on Wednesday, November 12th. Finally, Barclays cut their price target on Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a report on Wednesday, February 4th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, Amdocs currently has a consensus rating of “Moderate Buy” and a consensus target price of $92.33.

Amdocs Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.